Head, Biologics Development and Strategy Americas @ (November 2021 - August 2023)
Head, Process Strategy and Development Support @ (May 2019 - August 2023)
Sr. Director, Biologics Process Development @ Takeda Pharmaceuticals International Company (January 2005 - August 2023)
Senior Investigator @ Progenics Pharmaceuticals, Inc. (January 1998 - January 2004)
Research Assistant Professor @ University of Pennsylvania (January 1996 - January 1998)
Post-Doctoral Fellow @ Rockefeller University (January 1989 - January 1996)
Norbert Schuelke Education
University of Regensburg
Doctor of Philosophy (Biology, Philosophy)
1979-1988
Universität Regensburg
Norbert Schuelke Skills
Assay Development
Biopharmaceuticals
Biotechnology
CMO management
Chromatography
Clinical Development
Drug Development
Drug Discovery
FDA
GMP
IND
Life Sciences
Lifesciences
Manufacturing Process Improvement
Monoclonal Antibodies
Oncology
Pharmaceutical Industry
Pharmaceutical process development
Process Optimization (Manufacturing)
Protein Chemistry
Protein Purification
Purification
Team Leadership
Technology Transfer
Vaccines
Validation
Norbert Schuelke Summary
Norbert Schuelke, based in Walpole, MA, US, is currently a Chief Technology Officer at Timberlyne Therapeutics. Norbert Schuelke brings experience from previous roles at NorthStar Bioprocess Consulting LLC, Self-employed and Takeda. Norbert Schuelke holds a 1979 - 1988 Doctor of Philosophy in Biology, Philosophy @ University of Regensburg. With a robust skill set that includes Assay Development, Biopharmaceuticals, Biotechnology, CMO management, Chromatography and more. Norbert Schuelke has 4 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Norbert Schuelke?
Find contact details for 700 million professionals.